Han Fang Ji
Stephania tetrandra S.Moore
Also known as: Stephania Root Four(English) 防己(Chinese)
Han Fang Chi
Updated October 23, 2026 · Not yet clinically reviewed
Safety at a glance
5 recorded drug interactions, 1 major or contraindicated
Contraindications or side effects are listed
No toxicity grade is recorded. Most herbs in the catalogue carry none.
Traditional Chinese Medicine
- Category
- wind-damp dispelling
- Temperature
- Cold
- Taste
- Bitter,Pungent
- Channels
- Bladder,Spleen,Kidney,Lung
Functions
Promotes urination and reduces edema especially in the lower body; Expels Wind-Dampness and alleviates pain ( purges Damp-Heat )
Traditional uses
Han Fang Ji (Radix Stephaniae Tetrandrae), the root of Stephania tetrandra, is a bitter, pungent, cold herb that drains Dampness, entering the Bladder, Spleen, Kidney and Lung channels. It promotes urination and reduces edema, being especially valued for Damp accumulation in the lower body with leg swelling and difficult urination; a classic pairing is with Huang Qi in Fang Ji Huang Qi Tang for edema and heavy, achy limbs from Wind-Damp with Qi deficiency. It also expels Wind-Dampness and clears Damp-Heat to relieve hot, swollen, painful joints (Bi syndrome).
Safety note: authentic Stephania tetrandra does NOT contain aristolochic acid. Nephrotoxicity historically blamed on "Fang Ji" stemmed from fraudulent substitution with Aristolochia species (Guang Fang Ji, A. fangchi), which is banned. Correct botanical identification is essential; source only verified Stephania tetrandra.
Western herbalism
Pharmacological effects
- Analgesic: Total alkaloids (50 mg/kg), tetrandrine (30 mg/kg) and demethyltetrandrine (60 mg/kg) were analgesic in mice.
- Antiinflammatory and antiallergic: Tetrandrine and demethyltetrandrine reduced formaldehyde paw edema in rats; tetrandrine reduced burn inflammation in rabbits, anaphylactic shock, PCA and mediator release (SRS-A, histamine).
- Striated muscle relaxant: Alkaloids relax skeletal muscle (ED50 of total alkaloids 17.25 mg/kg i.p. in mice); quaternary derivative tetrandrine dimethiodium (metetrandrine) is stronger, about 1/4 as potent as curarine with 10-fold higher LD50.
- Cardiovascular: Tetrandrine is hypotensive in cats, dogs and rats, lowers portal pressure in portal-hypertensive rats, increases coronary flow, acts as a calcium antagonist, protects against experimental myocardial infarction, and is antiarrhythmic and antiplatelet.
- Antineoplastic: Tetrandrine inhibited several tumor cell lines in vitro and Ehrlich ascites carcinoma, hepatoma and sarcoma in vivo.
- Anti-silicosis: Tetrandrine (40 mg/rabbit i.m. three times weekly for 3 months) reversed experimental silicosis in rabbits and inhibited silicosis development and collagen/glycosaminoglycan accumulation in rats.
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 256.
Formulas using this herb
16 of 16 formulas
- Bi Xie Hua Du Tang · 10.00000g
- Da Qiang Huo Tang 大羌活汤
- Er Jia Jian Zheng Qi San 二加减正气散 · 9.00000g
- Fang Ji Fu Ling Tang 防己茯苓汤 · 9.00000g · chief
- Fang Ji Huang Qi Tang 防己黄芪汤 · chief
- Ji Jiao Li Huang Wan 己椒苈黄丸 · 30.00000g · chief
- Jia Wei Er Miao Wan 加味二妙丸 · 6.00000g
- Sang Zhi Shi Gao Zhi Mu Tang 桑枝石膏知母汤
- Shang Zhong Xia Tong Yong Tong Feng Wan 上中下通用痛风丸 · 9.00000g
- Shu Feng Huo Xue Tang 疏风活血汤 · 3.00000g
- Shu Jin Li An San 舒筋立安散
- Shu Jing Huo Xue Tang 疏经活血汤 · 1.80000g
- Xiao Xu Ming Tang 小续命汤
- Xuan Bi Tang 宣痹汤 · 15.00000g · chief
- Yi Yang Jiu Lian San · 1.50000g
- Zheng Gu Tang Yao · 12.00000g
Botanical
Stephania tetrandra is a perennial climbing vine of the Menispermaceae family native to southern China and Taiwan. It produces slender twining stems that scramble over neighboring vegetation, bearing alternate, peltate leaves with broadly rounded to triangular blades and long petioles attached near the center of the leaf. Small, inconspicuous greenish-yellow unisexual flowers are borne in axillary cymes, followed by small drupes that turn red at maturity. The plant develops thick, fleshy tuberous roots which are the principal medicinal organ; these are dug in autumn, sliced transversely, and dried. The transverse section shows characteristic radiating vascular bundles within a pale, starchy parenchyma, a feature used to distinguish it from related Menispermaceous and Aristolochiaceous species.
- Family
- Menispermaceae
- Pharmaceutical name
- Radix Stephaniae Tetrandrae
- Parts used
- root
- Plant type
- vine
- Native region
- Anhui, Hubei, Jiangxi, Zhejiang
Constituents
Tetrandrine
Bisbenzylisoquinoline alkaloid · Principal alkaloid of the root; the Chinese Pharmacopoeia sets a combined minimum of 1.6% tetrandrine plus fangchinoline in the dried root
An L-type voltage-dependent calcium channel antagonist that inhibits calcium influx into vascular smooth muscle, producing vasorelaxation and a measurable fall in blood pressure in spontaneously hypertensive rats; it also blocks two-pore channels and reverses P-glycoprotein-mediated multidrug resistance in vitro.
It is the compound that was absent from the adulterated Belgian slimming-clinic batches, and its presence or absence is the practical chemical marker distinguishing genuine Han Fang Ji from Aristolochia fangchi.
Fangchinoline
Bisbenzylisoquinoline alkaloid · Second major alkaloid; assayed together with tetrandrine to the 1.6% Pharmacopoeia minimum
Structurally identical to tetrandrine except for a hydroxyl in place of a methoxy group at C7, and shares its calcium-antagonist and antiproliferative activity in preclinical models, generally at somewhat different potency.
Cyclanoline
Quaternary protoberberine alkaloid · Minor constituent of the root
A water-soluble quaternary alkaloid reported among the minor alkaloids of the root; it is not the compound to which the drug's calcium-antagonist activity is attributed.
Fenfangjines
Bisbenzylisoquinoline alkaloids · Minor constituents, characterised as a structural series from the root
A family of minor bisbenzylisoquinoline alkaloids isolated from Stephania tetrandra root and used chemotaxonomically; their individual pharmacology is largely uncharacterised.
Drug interactions
Aristolochia fangchi (Guang Fang Ji)
Major · Life-threatening: end-stage renal failure and urothelial carcinoma · Evidence level: Established
This is a substitution hazard, not a pharmacological interaction, and the direction matters. Han Fang Ji, the root of Stephania tetrandra, is not itself nephrotoxic and contains no aristolochic acid. What harmed the Belgian slimming-clinic patients was that Aristolochia fangchi was dispensed in its place: analysis of the implicated batches found no tetrandrine but aristolochic acids instead.
The exposure mechanism is a three-way collision of trade names. Han Fang Ji (Stephania tetrandra), Guang Fang Ji (Aristolochia fangchi) and Mu Fang Ji (Cocculus species) are all traded as "Fang Ji" under the shared pinyin, and the dried root slices are difficult to tell apart by eye. Vanherweghem's 1993 Lancet series and the 1998 review of the outbreak documented over 100 cases of rapidly progressive interstitial renal fibrosis; Nortier's 2000 New England Journal of Medicine follow-up found urothelial carcinoma in 18 of 39 patients who underwent prophylactic nephroureterectomy, with aristolochic acid-DNA adducts in the tissue.
Aristolochic acid is a Group 1 human carcinogen and Aristolochia species are banned or restricted in the United States, the European Union, China and elsewhere; Stephania tetrandra is not.
Clinical note: Do not treat this as a reason to avoid Han Fang Ji; treat it as a reason to demand species-authenticated material. Source only from suppliers who identify to binomial and assay tetrandrine plus fangchinoline against the Pharmacopoeia minimum, and reject any product labelled only "Fang Ji" or "Fangji". If a patient has taken an unauthenticated Fang Ji product over months, especially in a weight-loss formula, check renal function and consider urological surveillance.
Antihypertensive drugs, particularly calcium channel blockers
Moderate · Additive hypotension, bradycardia · Evidence level: Probable
Tetrandrine is a genuine L-type calcium channel antagonist, not merely a calcium-blocking curiosity: it inhibits KCl-induced intracellular calcium rise and L-type calcium currents in vascular smooth muscle, and lowers blood pressure in spontaneously hypertensive rats and in hypertensive patients. Co-administration with dihydropyridines, verapamil, diltiazem or other antihypertensives is therefore expected to be additive on the same target.
Clinical note: Monitor blood pressure when adding Han Fang Ji to an established antihypertensive regimen, and warn patients about postural symptoms. The interaction is pharmacodynamic and dose-related; reducing the herb rather than the prescribed drug is usually the appropriate adjustment.
CYP3A4 substrates
Moderate · Raised plasma concentrations of co-administered substrate drugs · Evidence level: Possible
Tetrandrine inhibits CYP3A4 in vitro and alters the pharmacokinetics of co-administered CYP3A4 substrates in animal studies. Human pharmacokinetic interaction data for the whole decoction are lacking, so the magnitude at ordinary decoction doses is not established.
Clinical note: Exercise caution with narrow-therapeutic-index CYP3A4 substrates such as ciclosporin, tacrolimus and certain statins. Separate dosing does not reliably mitigate enzyme inhibition; monitor drug levels where they are routinely measured.
P-glycoprotein substrate chemotherapy (daunorubicin, doxorubicin, vincristine)
Moderate · Increased intracellular chemotherapy accumulation and toxicity · Evidence level: Possible
Tetrandrine is a well-characterised P-glycoprotein inhibitor and has been studied deliberately as a multidrug-resistance reversal agent; it produces persistent reversal of P-glycoprotein-mediated daunorubicin resistance in MOLT-4 leukaemia cells. The same mechanism that is exploited therapeutically would raise systemic exposure to P-glycoprotein substrate cytotoxics if the herb were taken unplanned alongside them.
Clinical note: Do not add Han Fang Ji to an active cytotoxic chemotherapy regimen without oncology input. The evidence is in vitro and in tetrandrine-specific trials, not in patients taking the crude decoction, so the size of the effect is unknown.
Hepatotoxic drugs, at sustained high tetrandrine dose
Moderate · Hepatocellular necrosis; drug accumulation in liver, lung, kidney and adrenal · Evidence level: Probable
Chronic toxicity studies in dogs found that tetrandrine at 40 mg/kg for two months produced focal hepatocyte necrosis and abnormal liver function, with frank hepatic necrosis after six months of continuous dosing, and demonstrated tissue accumulation in liver, lung, kidney and adrenal gland proportional to dose. Tetrandrine is also the only plant-derived drug approved in China for silicosis, where it is given long-term at 60 mg three times daily, and pulmonary and hepatic adverse effects are the recognised dose-limiting concerns of that regimen.
This toxicity belongs to isolated tetrandrine at pharmaceutical doses over months, not to ordinary short-course decoction use of the crude root, and the distinction should be preserved when counselling.
Clinical note: Avoid stacking prolonged high-dose tetrandrine with other hepatotoxins including alcohol, methotrexate or isoniazid. For long courses, check baseline and periodic liver function; for short decoction courses at conventional dosage this concern is largely theoretical.
Dosage
| Form | Amount | Frequency | Notes |
|---|---|---|---|
| decoction | 5–10 g | Daily | 中国药典 2020 monograph 【防己】【用法与用量】5~10g。 【性味与归经】苦,寒。归膀胱、肺经。 — Han Fang Ji (汉防己) is the same drug as Fang Ji (防己), Stephania tetrandra; 汉 is the qualifier that distinguishes it from 广防己 Guang Fang Ji, which is Aristolochia fangchi and must NOT be dispensed. That prefix pair exists specifically to separate the safe Menispermaceae drug from the aristolochic-acid one, so the two records are kept distinct rather than merged. Dose is the ChP 防己 value; see the fang-ji record, which carries the identical latin_name. |
Dui yao: classical pairings
Han Fang Ji + Huang Qi黄芪
Qi is strengthened to secure the exterior while water and wind-damp are drained, treating edema from qi deficiency.
Wind edema or wind-damp with sweating, heaviness and aversion to wind.
Core pair of a classical formula — Fang Ji Huang Qi Tang, Jin Gui Yao Lue (Zhang Zhongjing)
Evidence
Study design on record, not certainty of outcome.
- Systematic review / meta-analysis
- 1
- Observational / case report
- 3
- In vitro / animal
- 3
Misuse of Herbal Remedies: The Case of an Outbreak of Terminal Renal Failure in Belgium (Chinese Herbs Nephropathy)
Vanherweghem JL · The Journal of Alternative and Complementary Medicine · 1998 · systematic review
Systematic review / meta-analysis · Not yet verified
Review of the Belgian outbreak by the nephrologist who first described it. It states plainly that the prescribed Stephania tetrandra was inadvertently replaced by Aristolochia fangchi in the powdered extracts delivered to Belgium and France, and that phytochemical analysis of the batches labelled Stephania found aristolochic acids rather than tetrandrine.
Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)
Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL · New England Journal of Medicine · 2000 · cohort
Observational / case report · Not yet verified
Prospective cohort of 39 patients with end-stage aristolochic acid nephropathy who underwent prophylactic nephroureterectomy after taking a slimming preparation in which Aristolochia fangchi had been substituted for Stephania tetrandra. Urothelial carcinoma was found in 18 patients and mild to moderate dysplasia in 19 more, and aristolochic acid-DNA adducts were detected in the tissue.
This is the definitive documentation that the harm came from the substituted Aristolochia, not from Han Fang Ji.
Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs
Vanherweghem JL, Tielemans C, Abramowicz D, Depierreux M, Vanhaelen-Fastre R, Vanhaelen M, Dratwa M, Richard C, Vandervelde D, Verbeelen D, Jadoul M · The Lancet · 1993 · cohort
Observational / case report · Verified
The original Belgian case series identifying rapidly progressive interstitial renal fibrosis in young women attending a Brussels slimming clinic, and linking it to the Chinese herbal component of the regimen. Nine cases were reported initially; the outbreak eventually exceeded 100 patients.
Tetrandrine slows disease progression on high-resolution computed tomography and lung function decline in artificial stone-associated silicosis: a retrospective cohort study
Zhou S, Shi J, Chen Z, Bian L, Huang L, Mao L · BMC Pulmonary Medicine · 2025 · cohort
Observational / case report · Not yet verified
Retrospective cohort in artificial stone-associated silicosis, in which tetrandrine treatment was associated with slower radiographic progression on high-resolution CT and slower decline in lung function than in untreated controls. Tetrandrine is the only plant-derived drug approved in China for silicosis; this is observational rather than randomised evidence.
Tetrandrine, an alkaloid from S. tetrandra exhibits anti-hypertensive and sleep-enhancing effects in SHR via different mechanisms
Huang YL, Cui SY, Cui XY, Cao Q, Ding H, Song JZ, Hu X, Ye H, Yu B, Sheng ZF, Wang ZJ, Zhang YH · Phytomedicine · 2016 · animal
In vitro / animal · Verified
In spontaneously hypertensive rats, tetrandrine lowered blood pressure and separately increased non-rapid-eye-movement sleep, and the authors attribute the two effects to different mechanisms. Supports the antihypertensive pharmacology of the isolated alkaloid; it is an animal study, not a human trial.
Studies of the chronic toxicity of tetrandrine in dogs: An inhibitor of silicosis
Tainlin L, Tingyi H, Changqi Z, Peipei Y, Qiong Z · Ecotoxicology and Environmental Safety · 1982 · animal
In vitro / animal · Verified
Chronic dosing in dogs found that tetrandrine at 40 mg/kg for two months caused focal hepatocyte necrosis and abnormal liver function, progressing to hepatic necrosis by six months, and that the drug accumulated dose-proportionally in liver, lung, kidney and adrenal gland. This is the principal source for the high-dose hepatotoxicity warning.
Differentiation between two "fang ji" herbal medicines, Stephania tetrandra and the nephrotoxic Aristolochia fangchi, using hyperspectral imaging
Tankeu S, Vermaak I, Chen W, Sandasi M, Viljoen A · Phytochemistry · 2016 · in vitro
In vitro / animal · Not yet verified
Analytical authentication study. Hyperspectral imaging with chemometric modelling separated Stephania tetrandra from Aristolochia fangchi in powdered and sliced material, addressing the morphological similarity that drives the substitution. Laboratory method development rather than clinical research.
Safety
Contraindications
- NOTE: in Guangdong/Guangxi the root of Aristolochia fanchi Wu ex Chou et Hwang (Aristolochiaceae) is used as 'Guang Fang Ji'; it contains aristolochic acids linked to renal fibrosis, so caution in prescribing
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 256.
Side effects
- I.v. tetrandrine 300 mg caused local pain and phlebitis; 528 mg caused hemoglobinemia, hemoglobinuria or mild anemia; 840 mg caused acute glomerular necrosis
- Recommended treatment doses of 240-300 mg showed no toxic effect on hemogram, urine, liver/kidney function or ECG
- Most rabbits died after 20 mg/kg i.v. total alkaloids; dogs tolerated 23-25 mg/kg i.v.; cats died from cardiac and respiratory inhibition after 25 mg/kg i.v. tetrandrine
Source: Zhu YP. Chinese Materia Medica: Chemistry, Pharmacology and Applications. Harwood Academic, 1998, p. 256.
Cultural and historical
Shen Nong Ben Cao Jing · Han dynasty, compiled c. 200 BCE to 200 CE
Jin Gui Yao Lue (Essential Prescriptions of the Golden Cabinet), Zhang Zhongjing · Eastern Han dynasty, c. 220 CE
Ben Cao Gang Mu (Compendium of Materia Medica), Li Shizhen · Ming dynasty, 1578, printed 1596
Ben Cao Qiu Zhen (Seeking Truth in the Materia Medica), Huang Gongxiu · Qing dynasty, 1769
References
- Zhang Y, Qi D, Gao Y, Liang C, Zhang Y, Ma Z, Liu Y, Peng H, Zhang Y, Qin H, Song X, Sun X, Li Y, Liu Z. History of uses, phytochemistry, pharmacological activities, quality control and toxicity of the root of Stephania tetrandra S. Moore: A review. Journal of Ethnopharmacology. 2020 doi:10.1016/j.jep.2020.112995
- Jiang Y, Liu M, Liu H, Liu S. A critical review: traditional uses, phytochemistry, pharmacology and toxicology of Stephania tetrandra S. Moore (Fen Fang Ji). Phytochemistry Reviews. 2020 doi:10.1007/s11101-020-09673-w
- Bhagya N, Chandrashekar KR. Tetrandrine - A molecule of wide bioactivity. Phytochemistry. 2016 doi:10.1016/j.phytochem.2016.02.005
- Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: A worldwide problem. Kidney International. 2008 doi:10.1038/ki.2008.129
- Liu ZL, Hirano T, Tanaka S, Onda K, Oka K. Persistent reversal of P-glycoprotein-mediated daunorubicin resistance by tetrandrine in multidrug-resistant human T lymphoblastoid leukemia MOLT-4 cells. Journal of Pharmacy and Pharmacology. 2003 doi:10.1211/0022357022115
Look-alike names
- Fang Feng防风— Fang Feng / Fang Ji share their first syllable. Practitioner-reviewed; no published source.
- Guang Fang Ji— Listed among herbs confused through similar names; the European slimming-drug nephropathy cases are attributed there to Aristolochia fangchi (Guang Fang Ji) given where Stephania tetrandra (Fang Ji) was meant.